A cut off date for which stem cell lines could be used, however, would have no basis in science and could severely compromise European scientists' access to the best quality lines.
Komisijai ir pieņemamas aptuveni divas trešdaļas no Parlamenta nostājas projektā iekļautajiem grozījumiem.